http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 24 Sep 2025 16:15:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Press+Releases/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html <ul class="bwlistdisc"> <li> Expands access to much-needed iron therapy for millions of US patients </li> <li> Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches </li> <li> Strengthens US supply of injectable iron sucrose </li> </ul> <p> PRINCETON, N.J.--(BUSINESS WIRE)-- Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent approval by the US Food and Drug Administration (FDA)1. The product is now available for order and delivery across the United States. The launch of this iron sucrose formulation further expands the Sandoz US iron therapy portfolio. </p><p> Intravenous iron sucrose is http://www.streetinsider.com/Business+Wire/Sandoz+launches+affordable+iron+sucrose+injection+for+treatment+of+iron+deficiency+anemia+in+patients+with+chronic+kidney+disease+in+US/25372073.html Wed, 24 Sep 2025 16:15:00 -0500 A.06822034 A.16030647 A.17792863 A.30142833 A.32437804 O.00003102 O.00162576 O.00513499 O.20026344 O.34978779 O.53134629 SDZ SDZNY